A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples